With
the withdrawal of fenfluramine and dexfenfluramine from the US market, many people
have asked what they should do if they have taken these drugs. In order to try
to provide guidance, based on the best information known at present, the Centers
for Disease Control and Prevention, the Food and Drug Administration, and the
National Institutes of Health (all components of Department of Health and Human
Services) collaborated with experts within the medical community to develop interim
recommendations for patients. The interim recommendations were published in the
November 14th issue of the Morbidity and Mortality Weekly Report (MMWR). This
Fen/Phen information page includes these interim recommendations [11/13/97] and
a series of questions and answers about the recommendations [11/13/97].
*Many
cases are in the investigative stages, but make a complaint now and your case
can be evaluated. Find out if you are owed money for damages and injury?